Oversight and Investigations

Chairman:  Tim Murphy (PA-18)
Jurisdiction: 
Responsibility for oversight of agencies, departments, and programs related to the jurisdiction of the full committee, and for conducting investigations.

Members

Republicans

Chairman: Tim Murphy (PA)
Vice Chairman: Michael C. Burgess, M.D. (TX)
Marsha Blackburn (TN)
Phil Gingrey (GA)
Steve Scalise (LA)
Gregg Harper (MS)
Pete Olson (TX)
Cory Gardner (CO)
Morgan Griffith (VA)
Bill Johnson (OH)
Billy Long (MO)
Renee Ellmers (NC)
Joe Barton (TX)
Fred Upton (MI)

Democrats

Ranking Member: Diana DeGette (CO)
Bruce Braley (IA)
Ben Ray Lujan (NM)
Jan Schakowsky (IL)
G.K. Butterfield (NC)
Kathy Castor (FL)
Peter Welch (VT)
Paul Tonko (NY)
John Yarmuth (KY)
Gene Green (TX)
John D. Dingell (MI) (non-voting)
Henry A. Waxman (CA)

December 7, 2012 | Press Release

WASHINGTON, DC –House Energy and Commerce Committee leaders sent a letter to the International Academy of Compounding Pharmacists seeking information on the role of this industry association in assisting compounding pharmacies in their interactions with federal and state authorities.  A bipartisan group of committee leaders wrote, “Allegations that your association may have enc

>>
December 7, 2012 | Letter

Excerpt: Allegations that your association may have encouraged compounding pharmacists to attempt to impede FDA from evaluating the efficacy and safety of their products, if true, raise serious concerns about your actions.

To read the letter, click here.

>>
November 28, 2012 | Press Release

WASHINGTON, DC – After once again being selected by his colleagues to serve as Chairman of the U.S. House Committee on Energy and Commerce, Congressman Fred Upton (R-MI) today announced the committee leadership he intends to appoint for the 113th Congress and commented on key priorities for the future. Rep. Lee Terry (R-NE) will succeed Rep.

>>
November 19, 2012 | Press Release

WASHINGTON, DC – House Energy and Commerce Republican leaders late last week requested the Food and Drug Administration provide internal documents related to the deadly meningitis outbreak by November 30, 2012.

>>
November 19, 2012 | Letter

Excerpt: In order to effectively and responsibly address the question of clarifying or enhancing FDA’s authority over compounding pharmacies, the committee must identify what happened at the New England Compounding Center (NECC), and why FDA did not use its authority to take enforcement action against NECC until October 2012, after the meningitis outbreak.

>>
November 15, 2012 | Letter

Excerpt: We write to express our strong opposition to certain provisions relating to the Department of Energy’s nuclear defense and related programs in the House-passed national defense authorization bill.

>>

Pages